Skip to content
Home/ Gmp, Gcp and Glp Bundle
Gmp, Gcp and Glp Bundle

Gmp, Gcp and Glp Bundle

No customer reviews yet ISBN 9781041323402

This bundle brings together three essential books on the USA regulatory requirements for the discovery/development, clinical determination and production/testing of pharmaceutical products: Good Laboratory Practice for Nonclinical Studies, Good Clinical Practices in Pharmaceuticals, and the new eighth edition of Good Manufacturing Practices for Pharmaceuticals. It is a valuable resource for those with responsibilities for complying with the USA Code of Federal (CFR) regulatory requirements for good laboratory, clinical, and manufacturing practices for clinical trial and marketed pharmaceuticals in the United States.

The bundle is ideal for start up companies and those that wish to broaden their knowledge and career of this fascinating industry.

Good Laboratory Practice for Nonclinical Studies

The GLP regulations have been enacted since 1978 and are currently under a proposed FDA amendment to revise terminology and accommodate other changes relating to advances in technology related to the industry. This book provides a unique opportunity to access interpretation of the 21CFR58 regulatory requirements from leading industry experts with a vast knowledge and expertise in their fields. The approach used takes the regulations, provides interpretations and references to examples and regulatory actions. Data integrity and the use of electronic systems in compliance with 21CFR11 Electronic Records: Electronic Signatures are also discussed.

Key Features:

  • Unique volume covering FDA inspections of GLP facilities
  • Provides a detailed interpretation of GLP Regulations
  • Presents the latest on electronic data management in GLP
  • Describes GLP and computer systems validation
  • Can be referenced repeatedly in supporting daily hands on implementation of the CFR requirements

Good Clinical Practices in Pharmaceuticals

Good clinical practice (GCP) is a set of internationally recognized ethical and scientific quality requirements that must be followed when designing, conducting, recording, and reporting trials that involve the participation of human subjects. Compliance with GCP assures patients and the public that the rights, safety, and wellbeing of people taking part in studies are protected and that research data is reliable.Presents details on GCP, the international ethical, scientific, and practical standard to which all clinical research is conducted.

Key Features:

  • Provides the most up-to-date and best practices, techniques, and methodologies in good clinical practice.
  • Discusses applicable laws and regulations supporting GCP compliance, quality and operations.
  • Describes who is responsible for implementing and maintaining quality assurance and quality control systems to ensure that studies are conducted and data are generated, documented, and reported in compliance with the protocol.

Good Manufacturing Practices for Pharmaceuticals, Eighth Edition

This book provides insight into the world of pharmaceutical quality systems and the key elements that must be in place to change the business and organizational dynamics from task-oriented procedure-based cultures to truly integrated quality business systems that are self-detecting and correcting. Chapter flow has been changed to adopt a quality systems organization approach, and supporting chapters have been updated based on current hot topics including the impact of the worldwide supply chain complexity and current regulatory trends.

Key Features:

  • Presents insight into the world of pharmaceutical quality systems.
  • Analyzes regulatory trends and expectations.
  • Includes approaches and practices used in the industry to comply with regulatory requirements.
  • Discusses recent worldwide supply chain issues.
  • Delivers valuable information to a worldwide audience regarding the current GMP practices in the industry.

About the author

Product details

Pub dateMay 25, 2026
ISBN-101041323409
ISBN-139781041323402
LanguageEnglish
Last updated 2026-09-08 03:38
$550.02
In stock soon — order now to reserve your copy
Delivery by Monday, September 14, 2026
Qty
Sign in to Add to Saved list
Free delivery on orders over $35.
15-day returns. Any reason.
Secure checkout. We never store card details.

Readers who bought this also bought

More from Industries - Manufacturing
See all
Factory-Free Economy: Outsourcing, Servitization, and the Future of Industry
De-industrialization, accelerated by the financial crisis, is a long term process. The comparative advantage of emerging economies shifted towards more advanced goods and their growing populations commanded an increasing share in global demand. This shift towards a factory-free economy in high income countries has drawn the attention of policy makers in North America and Europe. Some politicians have articulated alarming views, initiating mercantilist or 'beggar-thy-neighbour' cost-competitiveness policies. Yet companies that concentrate research and design innovations at home but no longer have any factories there may be the norm in the future. This volume proposes an economic analysis of this phenomenon and includes 11 contributions which complement each other and tackle the problem from different angles. <p/>The evidence in this book suggests that de-industrialization is a process that happens over time in all countries, even China. One implication is that criticism of China is not likely to provide a solution to these long term trends. Another implication is that the distinction between manufacturing and services is likely to become increasingly blurry. More manufacturing firms are engaging in services activities, and more wholesale firms are engaging in manufacturing. One optimistic perspective suggests that industrial country firms may be able to exploit the high-value added and skill-intensive activities associated with design and innovation, as well as distribution, which are all components of the global value chain for manufacturing. <p/>Although this ongoing transformation of the industrial economies may be consistent with evolving comparative advantage, it has significant short-run costs and requires far-sighted investments. These include the costs to workers who are caught in the shift from an industrial to a service economy, and the need to invest in new infrastructure and education to prepare coming generations for their changing roles.<br>
$48.81